Position in INSM
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$12,749,654
+$6,432,002 QoQ
Shares Held
77,970
+114.8% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $89,889,169 across 7 Biotechnology names. INSM ranks #3 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
86,697 | $28,685,436 | |
| 2 | INCY |
Incyte Corp
|
259,048 | $24,381,597 | |
| 3 | INSM |
INSMED Inc
This page
|
77,970 | $12,749,654 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,903 | $10,673,645 | |
| 5 | RPRX |
Royalty Pharma plc
|
177,500 | $8,514,675 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,232 | $3,269,812 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
16,600 | $1,614,350 |
All Filings in INSM
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,749,654 | 77,970 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $6,317,652 | 36,300 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||